The Immunogenicity and Safety of Live Attenuated Poliomyelitis Vaccine (Human Diploid Cell)
Poliomyelitis
About this trial
This is an interventional prevention trial for Poliomyelitis focused on measuring Poliomyelitis, Vaccine, Safety, efficacy
Eligibility Criteria
Inclusion Criteria:Only subjects fulfilling all of the following criteria will be eligible for the study:
- People aged from 2 months to 4 months old.
- The subjects or subjects' guardians are able to understand and sign the informed consent
- The subjects or subjects' guardians allow to comply with the requirements of the protocol
- Subjects with temperature <=37.0°C on axillary setting
- The subjects have signed informed consent already
Exclusion Criteria:The subjects have never been vaccinated with any Poliomyelitis Vaccine.
-
Sites / Locations
- Institute of Medical Biology -Chinese Academy of Medical Sciences Kunming, Yunnan, China 650118
Arms of the Study
Arm 1
Arm 2
Experimental
Experimental
Live attenuated Poliomyelitis vaccine (human diploid cell)
Poliomyelitis(Live)Vaccine(Monkey Kidney Cell),Oral
6.15 lgCCID50(containing typeⅠattenuated poliomyelitis not lower than 6.0 lgCCID50,typeⅡnot lower than 5.0 lgCCID50,type Ⅲ not lower than 5.5 lgCCID50).
6.15 lgCCID50(containing typeⅠattenuated poliomyelitis not lower than 6.0 lgCCID50,typeⅡnot lower than 5.0 lgCCID50,type Ⅲ not lower than 5.5 lgCCID50).